C121H125ClF6N30O14S — CID 161438436
1-benzyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-4-carboxamide;2-chloro-5-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-propan-2-ylbenzamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-(trifluoromethoxy)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)benzamide (PubChem CID 161438436) has the molecular formula C121H125ClF6N30O14S and a molecular weight of 2405.03 g/mol. Its IUPAC name is 1-benzyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-4-carboxamide;2-chloro-5-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-propan-2-ylbenzamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-(trifluoromethoxy)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)benzamide.
| Compound Name | 1-benzyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-4-carboxamide;2-chloro-5-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-propan-2-ylbenzamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-(trifluoromethoxy)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)benzamide |
|---|---|
| PubChem CID | 161438436 |
| Molecular Formula | C121H125ClF6N30O14S |
| Molecular Weight | 2405.03 g/mol |
| Exact Mass | 2402.93 |
| IUPAC Name | 1-benzyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]piperidine-4-carboxamide;2-chloro-5-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-propan-2-ylbenzamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-(trifluoromethoxy)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)benzamide |
| SMILES | COc1cc2nc(-c3[nH]ncc3NC(=O)C3CCN(Cc4ccccc4)CC3)[nH]c2cc1OC.COc1ccc(C(C)C)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.COc1ccc(OC(F)(F)F)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.CSc1ccc(Cl)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)c1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccc(C(F)(F)F)cc1 |
| InChI | InChI=1S/C26H30N6O3.C25H28N6O3.C24H23F3N6O4.C23H23ClN6O2S.C23H21F3N6O2/c1-16(2)18-5-7-23(34-3)19(13-18)26(33)30-22-14-27-31-24(22)25-28-20-6-4-17(12-21(20)29-25)15-32-8-10-35-11-9-32;1-33-21-12-18-19(13-22(21)34-2)28-24(27-18)23-20(14-26-30-23)29-25(32)17-8-10-31(11-9-17)15-16-6-4-3-5-7-16;1-35-20-5-3-15(37-24(25,26)27)11-16(20)23(34)31-19-12-28-32-21(19)22-29-17-4-2-14(10-18(17)30-22)13-33-6-8-36-9-7-33;1-33-15-3-4-17(24)16(11-15)23(31)28-20-12-25-29-21(20)22-26-18-5-2-14(10-19(18)27-22)13-30-6-8-32-9-7-30;24-23(25,26)16-4-2-15(3-5-16)22(33)30-19-12-27-31-20(19)21-28-17-6-1-14(11-18(17)29-21)13-32-7-9-34-10-8-32/h4-7,12-14,16H,8-11,15H2,1-3H3,(H,27,31)(H,28,29)(H,30,33);3-7,12-14,17H,8-11,15H2,1-2H3,(H,26,30)(H,27,28)(H,29,32);2-5,10-12H,6-9,13H2,1H3,(H,28,32)(H,29,30)(H,31,34);2-5,10-12H,6-9,13H2,1H3,(H,25,29)(H,26,27)(H,28,31);1-6,11-12H,7-10,13H2,(H,27,31)(H,28,29)(H,30,33) |
| InChIKey | VYYJDHRYDXTAHC-UHFFFAOYSA-N |
| XLogP | 20.40 |
| TPSA | 531.57 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 173 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2405.03 |
| LogP ≤ 5 | 20.40 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 30 |